Hyperfine Toekomstige groei
Future criteriumcontroles 2/6
Hyperfine is forecast to grow earnings and revenue by 7.2% and 20.8% per annum respectively while EPS is expected to grow by 7.4% per annum.
Belangrijke informatie
7.2%
Groei van de winst
7.4%
Groei van de winst per aandeel
| Medical Equipment winstgroei | 17.4% |
| Inkomstengroei | 20.8% |
| Toekomstig rendement op eigen vermogen | n/a |
| Dekking van analisten | Low |
| Laatst bijgewerkt | 09 Aug 2024 |
Recente toekomstige groei-updates
Recent updates
Hyperfine appoints Maria Sainz as President, CEO
Oct 06Hyperfine GAAP EPS of -$0.33 misses by $0.06, revenue of $1.53M misses by $0.47M
Aug 10Hyperfine stock plunges 14% as CEO Dave Scott steps down
Jun 29Hyperfine (NASDAQ:HYPR) Is In A Good Position To Deliver On Growth Plans
Apr 04
Hyperfine: MR Imaging In A Swoop
Mar 09Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 12/31/2026 | 24 | -38 | N/A | N/A | 2 |
| 12/31/2025 | 19 | -40 | -45 | N/A | 2 |
| 12/31/2024 | 14 | -41 | -43 | N/A | 3 |
| 6/30/2024 | 12 | -41 | -41 | -41 | N/A |
| 3/31/2024 | 12 | -42 | -42 | -41 | N/A |
| 12/31/2023 | 11 | -44 | -43 | -42 | N/A |
| 9/30/2023 | 10 | -47 | -48 | -47 | N/A |
| 6/30/2023 | 10 | -49 | -52 | -51 | N/A |
| 3/31/2023 | 8 | -62 | -59 | -59 | N/A |
| 12/31/2022 | 7 | -73 | -73 | -72 | N/A |
| 9/30/2022 | 6 | -86 | -77 | -75 | N/A |
| 6/30/2022 | 4 | -89 | -75 | -72 | N/A |
| 3/31/2022 | 3 | -81 | -70 | -67 | N/A |
| 12/31/2021 | 1 | -65 | -50 | -47 | N/A |
| 9/30/2021 | 1 | -46 | -39 | -37 | N/A |
| 6/30/2021 | 1 | -35 | -34 | -32 | N/A |
| 3/31/2021 | 1 | -26 | -26 | -25 | N/A |
| 12/31/2020 | 0 | -23 | -23 | -22 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: HYPR is forecast to remain unprofitable over the next 3 years.
Winst versus markt: HYPR is forecast to remain unprofitable over the next 3 years.
Hoge groeiwinsten: HYPR is forecast to remain unprofitable over the next 3 years.
Omzet versus markt: HYPR's revenue (20.8% per year) is forecast to grow faster than the US market (8.9% per year).
Hoge groei-inkomsten: HYPR's revenue (20.8% per year) is forecast to grow faster than 20% per year.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Insufficient data to determine if HYPR's Return on Equity is forecast to be high in 3 years time